Media Coverage header image

Media Coverage

Advanced Search
  • 02082019
    360Dx

    A diagnostic test used by Mayo Clinic to detect a rare neurological disease involves standard techniques and is not subject to patent law, a federal appeals court ruled Wednesday. The appellate court's decision to uphold a district court ruling in the patent dispute effectively denied claims by Quest Diagnostics' Athena Diagnostics division that it was owed royalties for the testing. The US Court of Appeals for the Federal Circuit sided with Mayo in a 2-1 decision.

  • 02072019
    News Live

    Back in 2017, Microsoft first announced the new AI-powered research project under Healthcare NExT initiative that enables healthcare providers to easily create intelligent and compliant healthcare virtual assistants and chatbots. Last year, Microsoft announced the preview of Healthcare Bot service on Azure Marketplace that enabled healthcare organizations to build and deploy, AI-powered virtual health assistants and chatbots. Microsoft today announced the general availability of the service. Virtual health assistants built using this service can be used for enhancing processes, self-service support, and cost reduction efforts. Quest Diagnostics in Cary, NC recently built a bot using the Microsoft Healthcare Bot service. This bot helps Quest Diagnostics' patients in finding testing locations, schedule appointments and get answers to non-medical questions such as whether to fast before a blood test or when to expect results.

  • 02062019
    National Law Review, The

    Several large health insurance companies, including Aetna, Anthem, and Healthcare Service Corporation, have announced a collaboration with PNC Bank and IBM to utilize blockchain technology to “improve transparency and interoperability in the health care industry” and “address a range of industry challenges, including promoting efficient claims and payment processing, to enable secure and frictionless healthcare information exchanges, and to maintain current and accurate provider directories.” The Synaptic Health Alliance launched in April 2018 with Humana, MultiPlan, Quest Diagnostics, UnitedHealthcare and Optum.

  • 02062019
    NJ Biz

    Prism Capital Partners announced it is planning new developments at ON3, a 116-acre campus spanning the cities of Clifton and Nutley Township. The planned construction projects will add approximately 400,000 square feet of laboratory facilities. Prism also stated it is finalizing plans to build a four-story, 150,000-square-foot speculative laboratory building at ON3. Additionally, Quest Diagnostics, leading provider of diagnostic information services, will break ground imminently for a flagship laboratory on a 12-acre parcel. The 250,000-square-foot, owner-occupied lab will become the largest in Quest’s network of 20-plus major laboratory facilities across the country, and will employ more than 1,100 people.

  • 02052019
    Healthcare IT News Online

    As the industry moves beyond mere EHR adoption and meaningful use, small practices of 10 physicians or fewer told researchers that they want their EMRs to do more than just meet regulatory requirements, a new KLAS report on small physician practices finds. But first, they want the basics to just work better. That means tailoring usability for them and improving customer service. As part of this research, KLAS interviewed representatives from AdvancedMD, Allscripts, Aprima, athenahealth, Azalea Health, CareCloud, Cerner, CureMD, eMDs, Greenway Health, Kareo, NextGen Healthcare, Quest Diagnostics, and Virence Health (GE Healthcare) to determine how well the vendors were aligned with the small practices’ needs and what is driving dissatisfaction among small groups.

  • 02052019
    Finance

    Drug testing can be complicated. Much like a baseball player, you must learn the fundamentals of drug testing to execute a successful, drug-free workplace program. No one hits a home run the first time up to bat. Whether you are a drug testing rookie or a veteran, it’s important to understand the benefits of different specimen types and what test type fits the unique needs of your workforce. In our upcoming webinar series, Back to Basics, we take a closer look at the three most common test types for drug testing offered by Quest Diagnostics: urine, hair, and oral fluid.

  • 02052019
    SalesFuel

    Americans have multiple numbers at their fingertips, but some of the numbers that could be most important to their health are not among them. New research released today by Quest Diagnostics, the world’s leading provider of diagnostic insights, shows that a majority of adults don’t know vital health information for them or their family members, but nearly all would like to be able to access their health information online. Results from the “Know Your Numbers“ survey show that more people remember their social media log-ins, current bank balances, Wi-Fi-passwords and even the security code on the back of their credit card than they do important personal health data, including their blood type and cholesterol and blood sugar levels.

  • 02042019
    WBTV 3 News at 11 PM - WBTV-TV

    Mike Sims owns Charlotte CBD on Central Avenue in Charlotte. Their business is exploding and they’ve only been open 18 weeks. “We thought it would be successful but nothing like we’ve seen,” says Owens while a wave of customers shopped in his store. So what if you use a CBD product and have to take a random drug test? We posed that question to Dr. Barry Sample with Quest Diagnostics, the nation’s leading provider in drug testing, where millions of drug tests are administered every year.

  • 02042019
    Electrical Contractor

    A 2017 survey conducted by the National Safety Council found employee use of prescription drugs on the job had affected a majority of employers. The most significant effect was absenteeism or missed work (reported by 39 percent of respondents) followed by impaired or decreased job performance (reported by 29 percent) and safety concerns, such as injuries or near misses (reported by 15 percent). However, a more recent report from December 2018 is cause for even more concern—the use of non-prescription drugs in the workplace.

  • 02012019
    Electrical Contractor Online

    A 2017 survey conducted by the National Safety Council found employee use of prescription drugs on the job had affected a majority of employers. The most significant effect was absenteeism or missed work (reported by 39 percent of respondents) followed by impaired or decreased job performance (reported by 29 percent) and safety concerns, such as injuries or near misses (reported by 15 percent). However, a more recent report from December 2018 is cause for even more concern—the use of non-prescription drugs in the workplace. A new report published by Quest Diagnostics notes such drug use among the U.S. workforce is increasing at an alarming rate.

  • 02012019
    marketscreener.com

    Data detailed on Oncology - Chronic Lymphocytic Leukemia have been presented. According to news reporting originating from Marlborough, Massachusetts, by NewsRx correspondents, research stated, "The prognostic role of cytogenetic analysis is well-established in B-cell chronic lymphocytic leukemia (CLL). Approximately 80% of patients have a cytogenetic aberration." Our news editors obtained a quote from the research from Quest Diagnostics, "Interphase FISH panels have been the gold standard for cytogenetic evaluation, but conventional cytogenetics allows detection of additional abnormalities, including translocations, complex karyotypes and multiple clones.

  • 02012019
    MyHeadlinez Online

    In 2018, five major healthcare companies - Humana, MultiPlan, Optum, Quest Diagnostics, and UnitedHealthcare - formed the Synaptic Health Alliance (the `Alliance`) to explore how blockchain technology could resolve current healthcare issues.

  • 01312019
    Delta County

    Delta County residents will want to mark their 2019 calendars for Delta County community-wide health fairs which include early blood draw events in early February or health fairs in mid-March in Paonia, Cedaredge and Delta. Delta County Memorial Hospital Volunteers and Lions clubs in Delta, Cedaredge and Paonia will be partnering in the annual community health fair events again. There will be no price increases on the cost of any of the blood work in 2019. Quest Diagnostics will be providing the health screen results in a booklet format to help health fair participants easily understand the meaning of each of the health screen results.

  • 01312019
    The Fix

    Marijuana is the substance most often detected in workplace drug screenings, according to a new study. More and more employees are testing positive for drugs in workplace screenings, an increase that is concerning for some employers and safety specialists. According to a study by Quest Diagnostics, positive drugs tests have increased significantly in a two-year period between 2015 and 2017.

  • 01242019
    Yahoo Finance

    The idea of sunshine in a bottle vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. According to recent CDC statistics, approximately 45% of middle-aged women and 38% of middle-aged men report taking a vitamin D supplement, and hundreds of thousands of Americans get tested for vitamin D deficiency each year. VITAL was supported by the NIH. Manson reports she received grants from the NIH, nonfinancial support from BASF, Pharmavite, Pronova BioPharma and Quest Diagnostics during the conduct of the VITAL study. Ng has received research funding from Pharmavite. Bernal-Mizrachi, Clarke and Michos report no relevant financial disclosures.

  • 01242019
    CoinDesk

    IBM is collaborating with a group of major players in the healthcare space to improve the way sensitive data is shared and make health claims and transactions more efficient – all in the form of a “blockchain-based ecosystem.” In such a busy space it’s not surprising IBM is faced with some consortia competition. For example, in April of last year, Humana and United Health Group, two of the largest health insurers, teamed up on a blockchain pilot with data providers Quest Diagnostics, Multiplan and Optum.

  • 01222019
    PR Newswire

    Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year. The annual survey designated Quest Diagnostics as one of only five companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry category.

  • 01222019
    KQCW-TV Online

    Good Leads has experience in generating technology sales leads with providers such as Quest Diagnostics, Samsung Neurologica , Fuji Medical, Statlife and Quality Interactions and regularly attends HIMSS and RSNA conferences in support of their IT healthcare and radiology focused customers.

  • 01212019
    CAP Today

    Quest Diagnostics and Oxford Immunotec announced that Quest has completed its acquisition of the U.S. laboratory services business of Oxford Immunotec; the T-Spot.TB tuberculosis and the Accutix tick-borne disease testing services are now part of Quest’s portfolio of infectious disease testing services.

  • 01202019
    Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference
    PR Newswire

    Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco. Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, January 8, 2019 at 7:30 p.m. Eastern Time. Mr. Rusckowski and Mr. Guinan also will participate in a Q&A session moderated by the host analyst.

  • 01182019
    Finance

    The Centers for Disease Control and Prevention (CDC) reported that more than 70,000 people in the United States died of drug overdoses in 2017. That devastating number broke records as the highest number for any single year in our country’s history and contributed to a decrease in life expectancy. Today drug overdoses rank as the leading cause of death for adults under age 55. DownloadQuest Diagnostics white paper about how the opioid crisis affects the workplace.

  • 01182019
    360Dx

    UBS initiated coverage of Quest Diagnostics and Laboratory Corporation of America on Thursday with a Neutral and Buy rating, respectively. In a report, analyst Kevin Caliendo put a a 12-month price target in Quest's shares of $90 and wrote that while he believes Quest could take market share from LabCorp and other competing reference labs, his analysis of Quest's long-term strategic partnership with UnitedHealthcare, announced in May, "suggests less switching to Quest than is expected."

  • 01162019
    Becker's Hospital Review Online

    A recent press release by Quest Diagnostics released new research showing that majority of adults don't know their vital health information, but would like to be able to access their health information online.

  • 01162019
    Workers Compensation

    The rate of positive drug tests rose by double digits in five of 16 major U.S. workforce industry sectors from 2015 to 2017, according to a recent analysis by lab services provider Quest Diagnostics.

  • 01152019
    PatientEngagementHIT.com

    Patient health literacy and knowledge about their own medical information leaves a lot to be desired, leading to calls for better patient education about patient portal and data access, according to a survey conducted by Kelton Global on behalf of Quest Diagnostics.

Show 5102550100 per page